World News1 year ago
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
[ad_1] AbbVie on Wednesday said it will acquire neuroscience drugmaker Cerevel Therapeutics for roughly $8.7 billion. Under the terms of the deal, AbbVie will pay $45...
